¼¼°èÀÇ Àúħ½À¼ö¼ú ·Îº¿ ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2021-2031³â) : ¼¼°è ¹× Áö¿ª Á¡À¯À², µ¿Çâ, ¼ºÀå ±âȸ ºÐ¼® º¸°í¼­ : Á¦Ç° ¹× ¼­ºñ½º, ¿ëµµ, ÃÖÁ¾ ¿ëµµ, Áö¿ªº°
Minimally Invasive Surgery Robot Market Size and Forecast 2021 - 2031, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product and Services, Application, End Use, and Geography
»óǰÄÚµå : 1761161
¸®¼­Ä¡»ç : The Insight Partners
¹ßÇàÀÏ : 2025³â 06¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 214 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,450 £Ü 6,180,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù.
US $ 6,450 £Ü 8,957,000
PDF (Site License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷ÀåÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,450 £Ü 11,735,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¼¼°è ÃÖ¼Òħ½À¼ö¼ú·Îº¿ ½ÃÀå ±Ô¸ð´Â 2024³â 111¾ï 6,000¸¸ ´Þ·¯¿¡¼­ 2031³â 291¾ï 3,000¸¸ ´Þ·¯·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2025-2031³â 14.8%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)À» ³ªÅ¸³¾ Àü¸ÁÀÔ´Ï´Ù. Àúħ½À ¼ö¼ú ·Îº¿ ½ÃÀå ±Ô¸ð È®´ë¿¡ ±â¿©ÇÏ´Â ¿äÀÎÀ¸·Î ¹Ì¼¼¼ö¼ú Áõ°¡¿Í ¸¸¼ºÁúȯÀÇ À¯º´·ü Áõ°¡¸¦ ²ÅÀ» ¼ö ÀÖ½À´Ï´Ù. ±×·¯³ª ·Îº¿ ½Ã½ºÅÛÀÇ ³ôÀº ºñ¿ëÀÌ Àúħ½À ¼ö¼ú ·Îº¿ ½ÃÀåÀÇ ¼ºÀåÀ» ÀúÇØÇÏ´Â ¿äÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù.

AI¸¦ Ȱ¿ëÇÑ ¼ö¼ú Áö¿øÀº ÃÖ¼Òħ½À ¼ö¼ú ·Îº¿ÀÇ °¡Àå Çõ½ÅÀûÀÎ Æ®·»µå Áß ÇϳªÀÔ´Ï´Ù. ÀÌ´Â ÀΰøÁö´É(AI)°ú ¸Ó½Å·¯´×(ML) ¾Ë°í¸®ÁòÀ» ·Îº¿ ½Ã½ºÅÛ¿¡ ÅëÇÕÇÏ¿© ¼ö¼ú Á¤È®µµ¸¦ ³ôÀ̰í, ÀÇ»ç°áÁ¤À» °³¼±Çϸç, ¼ö¼ú Áß ½Ç½Ã°£ µ¥ÀÌÅÍ ºÐ¼®À» Áö¿øÇÕ´Ï´Ù. ÀÌ·¯ÇÑ AI ½Ã½ºÅÛÀº ¹æ´ëÇÑ ¾çÀÇ È¯ÀÚ µ¥ÀÌÅÍ, ¿µ»ó, ¼ö¼ú ±â·ÏÀ» ºÐ¼®ÇÏ¿© ¿Ü°ú Àǻ簡 ÃÖ¼±ÀÇ Ä¡·á ¹æÄ§À» ¼ö¸³ÇÒ ¼ö ÀÖµµ·Ï µ½½À´Ï´Ù. ¼ö¼ú Áß AI´Â Á¶Á÷ÀÇ Æ¯¼º, ÇÕº´Áõ °¡´É¼º, ÃÖÀûÀÇ Àý´Ü °æ·Î¿¡ ´ëÇÑ ½Ç½Ã°£ Çǵå¹éÀ» Á¦°øÇÏ¿© ÀÎÀ§ÀûÀÎ ½Ç¼ö¸¦ ÁÙÀ̰í ȯÀÚ °á°ú¸¦ °³¼±ÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÀÌ¹Ì ¿©·¯ ±â¾÷µéÀÌ ÀÚ»çÀÇ ·Îº¿ Ç÷§Æû¿¡ AI¸¦ Á¢¸ñÇϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, Intuitive Surgical(da Vinci Surgical System Á¦Á¶¾÷ü)Àº ¼ö¼ú Áß °¡ÀÌ´ø½º¸¦ °­È­Çϱâ À§ÇØ Intelligent Tissue Tracking ¹× Image Analytics¿Í °°Àº AI ±â¹Ý µµ±¸¸¦ µµÀÔÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¸ÞµåÆ®·Î´Ð(·Îº¿ ¼ö¼ú ½Ã½ºÅÛ 'ÈÞ°í(Hugo)' Ãâ½Ã)Àº ¼ö¼ú ¿µ»ó ºÐ¼® ¹× ¼º´É Çǵå¹éÀ» Áö¿øÇÏ´Â AI ±â´ÉÀ» °®Ãß°í ÀÖ½À´Ï´Ù.

CMR SurgicalÀº ¿µ±¹¿¡ º»»ç¸¦ µÐ ȸ»ç·Î Versius Surgical Robotic SystemÀ» °³¹ßÇß½À´Ï´Ù. ÀÌ È¸»ç´Â AI¿Í µ¥ÀÌÅÍ ºÐ¼®À» Ç÷§Æû¿¡ ÅëÇÕÇÏ¿© ¼ö¼ú ¿öÅ©Ç÷ο츦 ÃÖÀûÈ­Çϰí ÀÇ»ç°áÁ¤À» °­È­Çϱâ À§ÇØ AI ¾Ë°í¸®ÁòÀ» ÅëÇØ µ¥ÀÌÅ͸¦ ¼öÁýÇÏ°í ºÐ¼®ÇÏ¿© ¿Ü°ú ÀÇ»çÀÇ ¼º°ú, ±â±â »ç¿ë, ¼ö¼ú È¿À²¼º¿¡ ´ëÇÑ ÅëÂû·ÂÀ» Á¦°øÇÕ´Ï´Ù. CMR SurgicalÀº ¸ðµâ½Ä, ¼ÒÇü, µ¥ÀÌÅÍ ½º¸¶Æ® ·Îº¿ ½Ã½ºÅÛ¿¡ ÁßÁ¡À» µÐ CMR SurgicalÀÇ µ¥ÀÌÅÍ ±â¹Ý Á¢±Ù ¹æ½ÄÀº ¼ö¼ú °á°ú¿Í ÈÆ·ÃÀÇ Áö¼ÓÀûÀÎ °³¼±À» Áö¿øÇÕ´Ï´Ù. AIÀÇ È°¿ëÀº ¼ö¼úÀÇ Á¤È®µµ¸¦ Çâ»ó½Ãų »Ó¸¸ ¾Æ´Ï¶ó ½Ã¼³ °£ ÀÇ·áÀÇ ÁúÀ» Ç¥ÁØÈ­ÇÏ´Â µ¥¿¡µµ µµ¿òÀÌ µÇ°í ÀÖ½À´Ï´Ù.

AI´Â ºñµð¿À ¹× ¼¾¼­ µ¥ÀÌÅ͸¦ »ç¿ëÇÏ¿© ¿Ü°ú ÀÇ»çÀÇ ¼º°ú¸¦ Æò°¡ÇÏ°í °³¼±Á¡À» Á¦¾ÈÇÔÀ¸·Î½á ¼ö¼ú ÈÄ ºÐ¼® ¹× ¼ö¼ú ÈÆ·Ã¿¡µµ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. °è»ê ´É·Â°ú AI ¸ðµ¨ÀÌ ¹ßÀüÇÔ¿¡ µû¶ó, ¼ö¼ú ·Îº¿Àº ´õ¿í ÀÚÀ²ÀûÀ¸·Î Àΰ£ÀÇ °³ÀÔÀ» ÃÖ¼ÒÈ­Çϸ鼭 ÀÛ¾÷À» ¼öÇàÇÒ ¼ö ÀÖ°Ô µÇ¾î ´õ¿í ½º¸¶Æ®ÇÏ°í ¾ÈÀüÇÑ ¼ö¼ú ȯ°æÀ¸·Î ÀüȯÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ´Â ÇâÈÄ ¸î ³â µ¿¾È ÃÖ¼Òħ½À ¼ö¼ú ·Îº¿ ½ÃÀåÀÇ ¼ºÀå¿¡ ±â¿©ÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¿ëµµº° ÀλçÀÌÆ®

¿ëµµº°·Î´Â ÀϹݿܰú, ºÎÀΰú, ºñ´¢±â°ú, ½Å°æ¿Ü°ú, Á¤Çü¿Ü°ú, ±âŸ·Î ºÐ·ùµÇ¸ç, 2024³â¿¡´Â ÀϹݿܰú ºÎ¹®ÀÌ ÃÖ¼Ò Ä§½À ¼ö¼ú ·Îº¿ ½ÃÀå¿¡¼­ °¡Àå Å« Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ·Îº¿ ¼ö¼úÀ» ÅëÇØ ÀÇ»ç´Â ±âÁ¸ ±â¼ú·Î´Â ºÒ°¡´ÉÇß´ø ¿©·¯ °¡Áö º¹ÀâÇÑ ¼ö¼úÀ» º¸´Ù Á¤¹ÐÇϰí À¯¿¬ÇÏ°Ô Á¦¾îÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÏ¹Ý ¿Ü°ú¿¡¼­ °¡Àå ÀϹÝÀûÀÎ ·Îº¿ ¼ö¼ú¿¡´Â Å»Àå ¼ö¼ú, ´ëÀå ¼ö¼ú, ´ã³¶ ÀýÁ¦¼ú, ºñ¸¸ ¼ö¼ú µîÀÌ ÀÖ½À´Ï´Ù. Å»Àå, ´ëÀå¾Ï, ºñ¸¸ »ç·Ê°¡ Áõ°¡ÇÔ¿¡ µû¶ó ÀÏ¹Ý ¿Ü°ú ¼ö¼ú¿¡ ·Îº¿ ½Ã½ºÅÛÀÇ µµÀÔÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, ¿Ü°ú ÀÇ»çµéÀº 1,000¸¸ °Ç ÀÌ»óÀÇ ¼ö¼ú¿¡¼­ ´ÙºóÄ¡ ¼ö¼ú ½Ã½ºÅÛÀ» »ç¿ëÇϰí ÀÖ½À´Ï´Ù. ´ÙºóÄ¡ ½Ã½ºÅÛÀÇ ´ëÇ¥ÀûÀÎ ÀÓ»ó ¿ëµµ´Â ÀϹݿܰú¸¦ Æ÷ÇÔÇÑ ¾à 70¿© °³ÀÇ ÀÓ»ó Àü¹® ºÐ¾ß¿¡ °ÉÃÄ ÀÖ½À´Ï´Ù.

½ÃÀå ±â¾÷µéÀº Á¤Çü¿Ü°ú ¼ö¼ú¿ë »õ·Î¿î ·Îº¿ ½Ã½ºÅÛÀÇ ½ÂÀÎÀ» ¹Þ´Â °æ¿ì°¡ ´Ã°í ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, 2021³â 3¿ù, ¿Ü°ú ÀÇ»ç¿Í ȯÀÚ °£ÀÇ ÀÎÅÍÆäÀ̽º¸¦ µðÁöÅÐÈ­ÇÏ¿© ¼º´É °¡ÀÌµå ¼ö¼úÀÇ »õ·Î¿î ¿µ¿ªÀ» °³Ã´Çϰí ÀÖ´Â ÀÇ·á±â±â ±â¾÷ Asensus Surgical, Inc. SystemÀÇ FDA Ãß°¡ ½ÂÀÎÀ» ȹµæÇÏ¿© ¹Ì±¹ ³» ÀÏ¹Ý ¿Ü°ú ¼ö¼ú ÀûÀÀÁõ È®´ë¸¦ °¡´ÉÇÏ°Ô Çϸç Àúħ½À ¼ö¼ú ·Îº¿ ½ÃÀåÀÇ ¼ºÀå¿¡ ¹ÚÂ÷¸¦ °¡Çϰí ÀÖ½À´Ï´Ù.

Àúħ½À ¼ö¼ú ·Îº¿ ½ÃÀå º¸°í¼­ ÀÛ¼º ½Ã Âü°íÇÑ 1Â÷ ¹× 2Â÷ Á¤º¸´Â ¹Ì±¹ ¼ºÇü¿Ü°úÇÐȸ, ¹Ì±¹½ÉÀåÇÐȸ, ¼¼°èº¸°Ç±â±¸(WHO) µîÀÔ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼­·Ð

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå Á¶»ç ¹æ¹ý

Á¦4Àå Àúħ½À¼ö¼ú ·Îº¿ ½ÃÀå ±¸µµ

Á¦5Àå Àúħ½À¼ö¼ú ·Îº¿ ½ÃÀå : ÁÖ¿ä ½ÃÀå ¿ªÇÐ

Á¦6Àå Àúħ½À¼ö¼ú ·Îº¿ ½ÃÀå : ¼¼°è ½ÃÀå ºÐ¼®

Á¦7Àå Àúħ½À¼ö¼ú ·Îº¿ ½ÃÀå ºÐ¼® : Á¦Ç° ¹× ¼­ºñ½ºº°

Á¦8Àå Àúħ½À¼ö¼ú ·Îº¿ ½ÃÀå ºÐ¼® : ¿ëµµº°

Á¦9Àå Àúħ½À¼ö¼ú ·Îº¿ ½ÃÀå ºÐ¼® : ÃÖÁ¾ ¿ëµµº°

Á¦10Àå Àúħ½À¼ö¼ú ·Îº¿ ½ÃÀå : Áö¿ªº° ºÐ¼®

Á¦11Àå °æÀï ±¸µµ

Á¦12Àå ¾÷°è »óȲ

Á¦13Àå ±â¾÷ °³¿ä

Á¦14Àå ºÎ·Ï

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The minimally invasive surgery robot market size is expected to grow from US$ 11.16 billion in 2024 to US$ 29.13 billion by 2031; it is projected to register a CAGR of 14.8% during 2025-2031. The growing number of microsurgeries and the increasing prevalence of chronic diseases are noteworthy factors contributing to the expansion of the minimally invasive surgery robot market size. However, the high cost of robotic systems hinders the minimally invasive surgery robot market growth.

AI-driven surgical assistance is one of the most transformative trends in minimally invasive surgery robots. It involves integrating artificial intelligence (AI) and machine learning (ML) algorithms into robotic systems to enhance surgical precision, improve decision-making, and support real-time data analysis during procedures. These AI systems analyze vast amounts of patient data, imaging, and surgical history to assist surgeons in planning the best course of action. During surgery, AI can provide real-time feedback on tissue characteristics, potential complications, and optimal cutting paths, reducing human error and improving patient outcomes.

Several companies are already incorporating AI into their robotic platforms. For instance, Intuitive Surgical (the manufacturer of the da Vinci Surgical System) has introduced AI-driven tools such as Intelligent Tissue Tracking and Image Analytics to enhance intraoperative guidance. Moreover, Medtronic (which launched the Hugo robotic-assisted surgery system) is equipped with AI features that support surgical video analysis and performance feedback.

CMR Surgical is a UK-based firm that developed the Versius Surgical Robotic System. The company is incorporating AI and data analytics into its platform to optimize surgical workflows and enhance decision-making. Versius collects data, which is analyzed using AI algorithms to provide insights into surgeon performance, instrument usage, and procedural efficiency. This data-driven approach supports continuous improvement in surgical outcomes and training. CMR Surgical's focus on modular, compact, and data-smart robotic systems makes it well-suited for widespread hospital adoption, especially in regions with significant cost and space constraints. Their use of AI is not only improving surgical precision but also helping to standardize the quality of care across institutions.

AI also plays a crucial role in post-operative analytics and surgical training, using video and sensor data to evaluate surgeon performance and suggest improvements. As computing power and AI models advance, surgical robots will become more autonomous and capable of performing tasks with minimal human intervention, marking a shift towards smarter, safer surgical environments. This is expected to contribute to the growth of the minimally invasive surgery robot market in the coming years.

Application-Based Insights

Based on application, the minimally invasive surgery robot market is segmented into general surgery, gynecological surgery, urological surgery, neurosurgery, orthopedic surgery, and others. The general surgery segment held the largest minimally invasive surgery robot market share in 2024. Robotic surgery allows doctors to perform numerous complex procedures with more precision, flexibility, and control than is possible with conventional techniques. The most common robotic surgery procedures under general surgery include hernia repair, colorectal surgery, cholecystectomy, and bariatric surgery. The growing cases of hernia, colorectal cancer, and obesity are increasing the adoption of robotic systems for general surgery. For instance, surgeons use da Vinci surgical systems in more than 10 million procedures. There are ~70 representative clinical uses for da Vinci systems, spanning clinical specialties, including general surgery.

Market players are increasingly receiving approvals for new robotic systems for orthopedic surgeries. For instance, in March 2021, Asensus Surgical, Inc. (formerly TransEnterix, Inc.)-a medical device company that is digitizing the interface between the surgeon and patient to pioneer a new field of performance-guided surgery-received an additional FDA clearance for the Senhance Surgical System, allowing for an expansion of indications in general surgery in the US, thereby fueling the minimally invasive surgery robot market growth.

The American Society of Plastic Surgeons, the American Heart Association, and the World Health Organization are among the primary and secondary sources referred to while preparing the minimally invasive surgery robot market report.

Table Of Contents

1. Introduction

2. Executive Summary

3. Research Methodology

4. Minimally Invasive Surgery Robot Market Landscape

5. Minimally Invasive Surgery Robot Market - Key Market Dynamics

6. Minimally Invasive Surgery Robot Market - Global Market Analysis

7. Minimally Invasive Surgery Robot Market Analysis - by Product and Services

8. Minimally Invasive Surgery Robot Market Analysis - by Application

9. Minimally Invasive Surgery Robot Market Analysis - by End Use

10. Minimally Invasive Surgery Robot Market - Geographical Analysis

11. Competitive Landscape

12. Industry Landscape

13. Company Profiles

14. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â